In conjunction with the American Society of Retina Specialists, the Macula Society, the Retina Society and Club Jules Gonin
Friday, Nov. 13
Saturday, Nov. 14
Retina Subspecialty Day Video Abstract Submitter
Submit a video abstract for Retina Subspecialty Day.
The online submitter for Retina Subspecialty Day video abstracts closes Thursday, May 13.
Find information regarding video submission:
Pravin U. Dugel, MD; Jennifer I. Lim, MD
Program Planning Group
Pravin U. Dugel, MD; Jennifer I. Lim, MD; Carl D. Regillo, MD, FACS; Richard F Spaide MD
The 2015 Retina Subspecialty Day aims to provide a comprehensive and focused medical and surgical retina update for the retina subspecialist, interested ophthalmologist, and ophthalmologist in training. The meeting focuses on up-to-date, clinically and scientifically relevant retina topics presented by an international group of respected retina specialists. The major educational goals are to highlight new clinical and investigative information and to transfer it to the participant so that it is useful for patient care. The meeting attains these goals by engaging the participant in didactic presentations, panel discussions, audience response polling, and audience response question generation for moderated panels.
What Is The Professional Practice Gap That This Activity Will Address?
The gap is the challenge of understanding and implementing the most up-to-date clinical guidelines for the treatment of dry and wet AMD, macular edema due to diabetes and retinal vein occlusion, as well as for the use of numerous new vitreoretinal surgical instruments and techniques.
The intended target audience for this program is vitreoretinal specialists, members in fellowship training and general ophthalmologists who are engaged in the diagnosis and treatment of vitreoretinal diseases.
The goals of this program are to:
- Provide attendees with a comprehensive, state-of-the-art update on the diagnosis and management of vitreoretinal diseases.
- Provide insight into new and upcoming therapeutic options for the treatment of a variety of disorders.
Upon completion of this activity, participants should be able to:
- Explain the current management of macular edema secondary to retinal occlusive disease and diabetic retinopathy.
- Explain the pathobiology and management of atrophic and exudative AMD and other causes of CNV.
- Identify emerging developments in retinal imaging.
- Describe new vitreoretinal surgical techniques and instrumentation.
- Identify new developments in hereditary retinal degenerations, pediatric retinal diseases and ocular oncology.
- Summarize current and new clinical trial data for retinal diseases such as AMD, diabetic retinopathy and retinal vein occlusion
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses and guests are not eligible for CME credits.